Evidence map›Paper›PMID 31348523›Full record

ArticleInternational journal of cancer2020

Blood arsenic levels and the risk of familial breast cancer in Poland.

Wojciech Marciniak, Róża Derkacz, Magdalena Muszyńska, Piotr Baszuk, Jacek Gronwald, Tomasz Huzarski, Cezary Cybulski, Anna Jakubowska, Michał Falco, Tadeusz Dębniak and 7 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Evidence for Genotype-Specific Optimal Blood Lead Levels for Cancer Risk:International journal of molecular sciences · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Update of the risk assessment of inorganic arsenic in food.EFSA journal. European Food Safety Authority · 2024
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Wojciech MarciniakDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Róża DerkaczDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Magdalena MuszyńskaDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Piotr BaszukDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Jacek GronwaldDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Tomasz HuzarskiDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Cezary CybulskiDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Anna JakubowskaDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Michał FalcoRadiation Oncology Department, West Pomeranian Oncology Center, Szczecin, Poland.
Tadeusz DębniakDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.ORCID 0000-0002-3506-8932
Marcin LenerDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.ORCID 0000-0003-0747-4850
Oleg OszurekDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Katherine PullellaWomen's College Research Institute, Toronto, Ontario, Canada.
Joanne KotsopoulosWomen's College Research Institute, Toronto, Ontario, Canada.
Ping SunWomen's College Research Institute, Toronto, Ontario, Canada.
Steven A NarodWomen's College Research Institute, Toronto, Ontario, Canada.ORCID 0000-0001-5798-0626
Jan LubińskiDepartment of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.ORCID 0000-0003-2931-3003
Read-Gene (Poland) · PLPomeranian Medical University · PLUniversity of Toronto · CAWomen's College Hospital · CAWest Pomeranian University of Technology in Szczecin · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arsenic is recognized as a potent carcinogen at high concentrations, but the relationship between environmental arsenic and breast cancer risk has not well been studied. Most research has focused on the effect of arsenic in populations with high endemic exposure, and not in populations with arsenic levels within normal limits. We sought to determine if blood arsenic levels predict the risk of breast and other cancers risk among women in northern Poland. The cohort consisted of 1,702 healthy women, aged 40 and above, identified between 2010 and 2017. Blood arsenic level was determined by inductively coupled plasma mass spectrometry. After an average of 4.5 years of follow-up (range 0.7-7.3 years), there were 110 incident cases of cancer diagnosed in the cohort, including 68 cases of breast cancer. Women in the highest quartile of arsenic had a highly significant 13-fold increased risk of developing breast cancer, compared to women in the lowest quartile (hazard ratio [HR] = 13.2; 95% confidence interval [CI] 4.02-43.0). Results were similar for arsenic and all incident cancers (HR quartile 4 vs. quartile 1 = 13.3; 95% CI 4.78-37.0). If confirmed, our study suggests that the blood arsenic level may be a useful predictive marker of cancer risk in women.

Indexed as

AdultAgedArsenicBreast NeoplasmsEnvironmental ExposureFemaleGenetic Predisposition to DiseaseHumansIncidenceMiddle AgedPolandRisk FactorsArsenicarsenicbloodcancercancer riskcohort studyfamilial breast cancerPolandprospective study

Identifiers

PMID31348523
PMCPMC7154768
OpenAlexW2966821095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.